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Abstract 
 
 
The objective of this paper was to investigate the effects of a Chinese Materia Medica variant -Fubao Danggui Jiao 
(FDJ)-on experimental endometriosis. An endometriosis model was created by virtue of auto-transplantation of endometrial 
tissue onto rats’ abdominal walls. The implants were allowed to grow for 30 days until the successful completion of 
the model. After that, forty endometriotic rats were randomly divided into four study groups and given different treatments: 
(1) negative control group (water, 2ml/kg, per os); (2) FDJ-A group (FDJ, 2ml/kg, per os); (3) FDJ-B group (FDJ, 4ml/kg, 
per os); (4) Danazol group (70mg/kg, per os). After 30 days with treatments, the volumes of endometriotic implants in each 
rat were measured. The implants and normal uterine horns were removed for routine histological examination. FDJ caused 
significant decreases in volumes of the surviving endometriotic implants, with two different doses having statistically 
equivalent effects. Upon histological examination, FDJ was observed to cause regression of epithelium and stroma of 
endometriotic implants. FDJ had revealed promising therapeutic effects on endometriosis. 
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Introduction 
 
 
Endometriosis is a common, chronic, estrogen-dependent gynecological disorder. In women of reproductive age, its 
incidence is as high as 10%, while that of infertile women is, over 35% (Vigan et al., 2004). Although the etiology of this 
disease remains unclear, the theory of retrograde menstruation is a widely accepted as an underlying mechanism, because the 
theory in reference explains how endometrial cells  manage  to present at ectopic sites. Nevertheless, the theory 
cannot account for the fact that these misplaced cells survive in women with endometriosis but not in healthy women 
(Gazvani et al., 2002; Nap et al., 2004; Tsaltas et al., 1998; Vinatier et al., 2001). 
Although endometriosis represents a form of benign hyperplasia, it can infiltrate, metastasize and relapse in form of 
a cancer. It may cause pelvic pain, progressive dysmenorrhea, dyspareunia, and even infertility (Amer, 2008; Arya et al., 
2006). The currently accepted medical treatments for this disease involve administration of Danazol, gonadotropin-releasing 
hormone agonists (GnRHa), progestogens, and oral contraceptives. In a word, these agents suppress the growth of ectopic 
endometrial  tissues  by  inducing  a  hypoestrogenic  state.  However,  hypoestrogenism  supresses  the  growth  of  normal 
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endometrium and prevents spontaneous ovulation. All of these medicines are therefore of limited value in patients who want 
to have children. Moreover, these therapies may cause various side-effects at high incidences, such as weight gain, abnormal 
lipid metabolism, liver dysfunction, thrombosis, and menopause-like symptoms (Olive et al., 2004; Rizner, 2009; Vercellini 
et al., 2008). Therefore, new medical strategies are needed to prevent the development of endometriosis. 
In  oriental  countries,  Chinese  Materia  Medica  has  a  thousands-of-years  long  history  of  use.  Many  ancient 
prescriptions of Chinese Materia Medica have been handed down across generations, and are widely used because of their 
satisfactory therapeutic efficacy and low incidence of side-effects. Thus,  researchers are searching for safe and 
effective Chinese Materia Medica variants to treat this intractable disease, endometriosis (Han et al., 2008; Qu et al., 2005; 
Wang et al., 2008; Zeng et al., 2006; Zhang et al., 2009; Zheng et al., 2005). 
Fubao Danggui Jiao (FDJ) originates from Jiao Ai Tang, which is an ancient prescription of Chinese Materia Medica. 
Jiao Ai Tang was first mentioned in the Synopsis of the Golden Chamber written by Zhongjing Zhang of China in 219 A.D. It 
has remedial effects in terms of abortion prevention, and can regulate menstruation (Duan et al., 1984). Later generations 
chose four constituents of Jiao Ai Tang to develop a new extraction named the Decoction of Four Drugs. The Decoction of 
Four Drugs is a water extract of Chinese Angelica, Szechwan Lovage Rhizome, prepared Rehmannia root, and White Peony 
Alba. It enriches the blood,  regulates menstruation, and absorbs clots (Xie, 1997). FDJ is a water extract based on 
the Decoction of Four Drugs with Colla Corri Asini, Indian Bread, Tangshen, Milkvetch root, and Radix Glycyrrhizae added. 
It was first introduced into the Chinese market in 1950s, and later into Japan. Its main function is to invigorate vital 
energy, enrich the blood, and regulate menstruation. This paper is the first to study the effects of FDJ on experimental 
endometriosis. 
 
 
 
Materials and Methods 
Test Drugs 
 
 
FDJ was kindly provided by Iskra Industry Co., Ltd., Japan. FDJ is a water extract of Chinese Angelica, Colla 
Corri Asini, Szechwan Lovage Rhizome, prepared Rehmannia root, White Peony Alba, Indian Bread, Tangshen, Milkvetch 
Root, and Radix Glycyrrhizae. Danazol capsules were produced by Jiangsu Lianhuan Pharmaceutical Co., Ltd., China. 
 
 
Animals 
 
 
Female Sprague-Dawley rats of specific pathogen-free (SPF) level, aged 8 weeks and weighing  250g±25g, 
were purchased from the Animal Department of Tongji Medical College, Huazhong University of Science and Technology, 
Permit Number: SYXK (Hubei) 2004-0028. All of the rats were kept in a SPF-level lab at the room temperature of 23±2, 
relative humidity of 55±15%, with 12:12 light/ dark alteration. Approval of the protocol was obtained from the Institutional 
animal ethics committee. 
 
 
 
Methods 
 
 
Forty female rats were injected with 1mg/kg of diethylstilbestrol to stimulate estrus. After that,  laparotomy 
was carried out under diethyl ether anesthesia. The left uterine horn was resected, and the endometrium was dissected from 
the myometrium. The endometrium was subsequently cut into 5*5 mm2   - fragments. Four endometrial tissue fragments 
were implanted into the abdominal wall of the same rat, with epithelium facing the abdominal cavity. Next, streptomycin 
solution (52.5 mg/kg) was dropped into the  abdominal cavity so as to prevent infection. Finally, the wound was sewn 
up. The operation was conducted in a strict accordance with the aseptic technique. 
Thirty days after the surgery, the rats were randomly divided into four study groups and given different treatments: 
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(1) negative control group (water, 2ml/kg, per os);(2) FDJ-A group (FDJ, 2ml/kg, per os); (3) FDJ-B group (FDJ, 4ml/kg, 
per os); (4) Danazol group (70mg/kg, per os) as the positive control. After 30 days of treatments,  the volumes of 
surviving implants were evaluated by virtue of measuring their dimensions (length, width,  height), volume thereby 
being equal to length*width*height. T-test was utilized for statistical analysis. In addition, the surviving implants and 
normal right uterine horns were removed and fixed in 10%-formalin for routine histological examination in form of 
hematoxylin – eosin (H-E) stained paraffin sections. The sections were examined under light microscope (200×) and 
photomicrograped. 
 
 
Table 1: Volumes of ectopic endometrial tissues across study groups after 30 days of treatments 
Study Group Dose Volume (mm3) 
 
Negative Control 0 125.3±103.7 
 
FDJ-A 2ml/kg 63.2±48.2* 
 
FDJ-B 4ml/kg 58.5±52.4* 
 
Danazol 70mg/kg 41.2±27.4* 
 
 
All values are expressed as   x ±s. *P<0.05 vs negative controls. 
 
 
 
 
Results 
Volumes of Endometriotic Implants 
 
 
After 30 days of treatments, the surviving endometriotic rat implants had grown well and had transformed into cystic 
structures protruding from the abdominal walls (Figure 1). The implants that failed to survive either perished or turned into 
small hard sites. On the surface of some of the surviving cysts, several newly-formed blood vessels had been observed, while 
some of the cysts contained a bright-yellow secrete inside their cavities. In addition, some of the cysts were closely adhered 
to the surrounding tissues. 
FDJ  caused  a  significant  decrease  in  volumes  of  the  surviving  ectopic  endometrial  tissues,  with  two  doses 
statistically equally effective (P>0.05). The volumes of the implants seen in the FDJ-A and FDJ-B arms were statistically 
equivalent to those seen in the Danazol arm (P>0.05). Table 1 shows the volumes of the ectopic endometrial tissues seen in 
each animal group. 
 
 
Histological Examination of Implants and Uterine Tissue 
 
 
In the surviving implant sections across the negative control group, inflammatory hyperplasia in terms of stratified 
epithelia and dense inflammatory cell infiltration    had been seen. In the FDJ and Danazol arms, some of the epithelial cells 
had atrophied into small cubic cells. In FDJ and Danazol -treated rats, stromal cells were arranged loosely (Figure 2). 
In the right uterine horn sections, stromal inflammatory cell infiltration indicative of uterine inflammation had been 
seen with the negative controls, whereas the FDJ and Danazol groups had exhibited no pathology whatsoever (Figure 3). 
 
 
 
Discussion 
 
 
Experimental  results  of  the  study  presented  herein,  indicated  that  a  30  day-FDJ  administration  is  capable of 
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effectively inhibiting the growth of endometriotic implants. Upon histological examination, it was observed that FDJ caused 
 
 
 
Figure 1: Surviving endometriotic implants 
 
The surviving implants had grown to form cystic structures. Inside the cysts, transparent secrete had been found (arrow). 
 
 
Figure 2: Sections of surviving implants (H-E staining; original magnification, 200×) 
 
a. In the negative control group, epithelial cells of ectopic endometria had proliferated to form stratified epithelia (horizontal 
arrow). In these negative controls, chronic inflammatory cells were observed as well (vertical arrow). b. In FDJ-treated rats, 
epithelial cells of ectopic endometria had atrophied into a cubic  shape  (horizontal arrow). The cells in the stroma 
were arranged loosely (vertical arrow). c. In the ectopic endometria of Danazol-treated rats, normal, simple columnar 
epithelia had been seen (arrow). 
 
 
Figure 3: Uterine tissue sections (H-E staining; original magnification, 200×) 
 
a. In the negative controls, inflammatory cell infiltrations of the uterine stroma had been seen (arrow). b. In FDJ-treated rats, 
uterine  tissue  presented  with  no  pathological  changes  at  all.  c.  In  Danazol-treated  rats,  the  uteri  presented  with  no 
pathological changes at all. 
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regression  of  epithelium  and  stroma  in  endometriotic  implants.  All  of  these  results  suggest  that  FDJ  has  promising 
therapeutic effects on endometriosis, statistically equivalent to those of Danazol. Moreover,  the two doses exhibited 
no significant difference in efficacy of endometriosis management. 
For decades now, FDJ has been used as a potent agent in drug treatment of irregular menstruation and deficiency of 
both vital energy and blood. However, its effects on endometriosis have never been examined before. The present study was 
the first to investigate the effects of FDJ on experimental endometriosis as its newly-discovered pharmacological potential. 
FDJ is a water extract of several medicinal ingredients, including Chinese Angelica, Colla Corri Asini, Szechwan 
Lovage  Rhizome,  prepared  Rehmannia  root,  White Peony Alba,  Indian  Bread,  Tangshen,  Milkvetch  root,  and  Radix 
Glycyrrhizae. In traditional Chinese medicine Chinese Angelica is perceived as acrid-sweet in flavor and warm in nature; it 
enriches the blood, enhances blood circulation so as to alleviate pain, nourishes the liver, and regulates menstruation. Colla 
Corri Asini is sweet in flavor and neutral in nature; it stopps bleeding, absorbs clots, and nourishes the blood and kidney. 
Szechwan Lovage Rhizome is pungent  in flavor and fragrant in nature; it can increase vital energy and enhance 
blood circulation. Prepared Rehmannia root is sweet in flavor and warm in nature; it can nourish yin, supplement blood, and 
tonify the marrow. White Peony Alba is bitter-sour in flavor and cool in nature; it nourishes the blood and liver, puts 
down the middle warmer energy to alleviate pain, and decreases yin exhaustion by stopping excessive perspiration. 
Indian Bread is sweet in flavor and bland in nature; it can act as diuretic, supplement vital energy, and invigorate the 
spleen. Tangshen is sweet, slightly sour in flavor and mild in nature, while Milkvetch root is sweet in flavor and slightly 
warm in nature. Their actions are the same - invigoration of vital energy and spleen. Radix Glycyrrhizae is sweet in flavor 
and neutral in nature; it can invigorate vital energy and harmonize the nature of various medicinal ingredients (Li, 2002). 
According to the traditional Chinese medical theory, endometriosis is an endometrial proliferation arising due to the 
stagnation of vital energy and blood outside the uterine cavity (Li et al., 2003). FDJ contains several ingredients capable of 
enhancing vital energy and blood circulation. Therefore, we theoretically deduced that FDJ has some promising properties 
possibly of use for endometriosis therapy. 
In the present study, we investigated the therapeutic effects of FDJ. The results had demonstrated its effectiveness in 
suppressing  endometriotic  implants’ growth.  It  was  therefore  deduced  that  FDJ  has  promising  therapeutic  effects  on 
endometriosis; thus, further research is needed in order to further clarify its acting mechanisms and confirm its effectiveness 
in endometriosis. Additionally, the results of histological examinations of uterine tissue samples demonstrated that FDJ has 
an  anti-inflammatory  effect  as  well.   Uterine  inflammation  may  induce  oviduct  inflammation;  should  an  
oviduct inflammation become serious, it may result in oviduct obstruction and cause infertility. Our experimental results 
suggest the need for future research on therapeutic effects of FDJ on oviduct obstruction developed due to inflammation. 
The present study showed that, by virtue of inhibiting the proliferation of ectopic endometrial tissues, FDJ may be of 
therapeutic value in endometriosis. 
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